CSF Immunological Biomarkers Associated with Axonal Damage in Multiple Sclerosis

被引：0
|
作者：
Villar, Luisa [1 ]
Picon, Carmen [1 ]
Alenda, Raquel [1 ]
Garcia-Caldentey, Juan [1 ]
Costa-Frossard, Lucienne [1 ]
Espino, Mercedes [1 ]
Alvarez-Cermeno, Jose [1 ]
机构：
[1] Hosp Ramon & Cajal, IRYCIS, E-28034 Madrid, Spain
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P03237
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Glutamate excitotoxicity and axonal damage in multiple sclerosis.
    Werner, P
    Pitt, D
    Raine, CS
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (05): : 431 - 431
  • [32] Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
    Zjukovskaja, Christina
    Larsson, Anders
    Cherif, Honar
    Kultima, Kim
    Burman, Joachim
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [33] Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
    Zjukovskaja, Christina
    Larsson, Anders
    Cherif, Honar
    Kultima, Kim
    Burman, Joachim
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [34] Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
    Stilund, Morten
    Gjelstrup, Mikkel Carstensen
    Petersen, Thor
    Moller, Holger Jon
    Rasmussen, Peter Vestergaard
    Christensen, Tove
    PLOS ONE, 2015, 10 (04):
  • [35] Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis
    Zetterberg, H.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 : 15 - 17
  • [36] Searching for early CSF biomarkers of primary progressive multiple sclerosis
    Marastoni, D.
    Magliozzi, R.
    Rossi, S.
    Monaco, S.
    Calabrese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 882 - 883
  • [37] Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
    Ottervald, Jan
    Franzen, Bo
    Nilsson, Kerstin
    Andersson, Lars I.
    Khademi, Mohsen
    Eriksson, Bodil
    Kjellstrom, Sven
    Marko-Varga, Gyorgy
    Vegvari, Akos
    Harris, Robert A.
    Laurell, Thomas
    Miliotis, Tasso
    Matusevicius, Darius
    Salter, Hugh
    Ferm, Mats
    Olsson, Tomas
    JOURNAL OF PROTEOMICS, 2010, 73 (06) : 1117 - 1132
  • [38] Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
    Bielekova, Bibiana
    McDermott, Michael P.
    NEUROLOGY, 2015, 84 (16) : 1620 - 1621
  • [39] CSF biomarkers do not associate to early disability in Multiple Sclerosis
    Vecchio, D.
    Crespi, I.
    Clemente, N.
    Virgilio, E.
    Chiocchetti, A.
    Bellomo, G.
    Cantello, R.
    Comi, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 535 - 535
  • [40] Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
    Gunnarsson, Martin
    Malmestrom, Clas
    Axelsson, Markus
    Sundstrom, Peter
    Dahle, Charlotte
    Vrethem, Magnus
    Olsson, Tomas
    Piehl, Fredrik
    Norgren, Niklas
    Rosengren, Lars
    Svenningsson, Anders
    Lycke, Jan
    ANNALS OF NEUROLOGY, 2011, 69 (01) : 83 - 89
12345